WAYMADE-TRIENTINE DIN 02515067
Health Canada record
| Active ingredient(s) | TRIENTINE HYDROCHLORIDE 250 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | A16AX12 TRIENTINE |
| Original market date | 05-Jul-2021 |
| Current status date | 05-Jul-2021 |
| Source | Health Canada DPD |
Establishment licence of the holder
Waymade PLC — licence , not currently licensed, last inspection rating C (2023-02-13).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TRIENTINE HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02504855 | MAR-TRIENTINE | MARCAN PHARMACEUTICALS INC | Capsule | TRIENTINE HYDROCHLORIDE 250 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 25729 | 2021-04-20 | New Drug Submission (NDS) |
International API supply for TRIENTINE HYDROCHLORIDE
9 active FDA Drug Master Files.
Request a quote for WAYMADE-TRIENTINE